CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net loss	$ (4,111,844)	$ (11,660,897)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,318	8,946
Equity-based compensation expense	222,685	439,462
Grant receivable write-off	0	130,000
Changes in operating assets and liabilities:
Grants receivable	0	1,480,490
Prepaid expenses and other assets	506,888	671,848
Accounts payable	(437,052)	(1,769,690)
Accrued expenses and other current liabilities	33,186	(635,067)
Net cash used in operating activities	(3,782,819)	(11,334,908)
Financing activities
Proceeds from issuance of equity securities, net	1,526,460	6,920,530
Payments on note payable	(359,522)	(111,469)
Net cash (used in) provided by financing activities	1,166,938	6,809,061
Net decrease in cash, cash equivalents and restricted cash	(2,615,881)	(4,525,847)
Cash, cash equivalents and restricted cash at beginning of period	5,899,910	12,106,435
Cash, cash equivalents and restricted cash at end of period	3,284,029	7,580,588
Non-cash investing and financing activities:
Cash paid for interest	12,064	6,799
Accrued issuance costs for issuance of equity securities	0	0
Insurance premium financed by note payable	$ 398,728	$ 570,560